American Century Companies Inc Fulcrum Therapeutics, Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 120,611 shares of FULC stock, worth $447,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,611
Previous 113,841
5.95%
Holding current value
$447,466
Previous $406,000
39.41%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FULC
# of Institutions
134Shares Held
52.8MCall Options Held
3.08MPut Options Held
316K-
Ra Capital Management, L.P. Boston, MA10.2MShares$37.9 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$19.5 Million2.43% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$17.7 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$12.4 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $193M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...